Fox Chase Cancer Center

Articles

Race Shown to Predict Survival Disparities in Head and Neck Cancer Clinical Trials

December 7th 2022

A study published by researchers at Fox Chase Cancer Center suggests that race itself may predict disparate outcomes between patients with head and neck cancer.

Fox Chase Study Reveals Mechanism for Repairing DNA Damage Caused by Environmental Triggers

December 2nd 2022

It’s long been known that DNA damage caused by environmental triggers, as well as other sources of oxidative stress, contribute to the development and progression of a wide variety of cancers.

Two Fox Chase Researchers Receive Grants to Pursue Innovative Kidney Cancer Research

November 29th 2022

Two Fox Chase Cancer Center researchers have received $75,000 grants from the Kidney Cancer Association to pursue studies that could improve kidney cancer treatment and care.

Dr. Robert Uzzo Appointed President and CEO of Fox Chase Cancer Center

November 9th 2022

Robert Uzzo, MD, MBA, FACS, has been formally named president and chief executive officer of Fox Chase Cancer Center following a period of interim leadership.

Fox Chase Cancer Center Welcomes Charnita Zeigler-Johnson

October 19th 2022

Fox Chase Cancer Center is pleased to announce the hiring of Charnita Zeigler-Johnson, PhD, MPH, as Associate Director of Community Outreach and Engagement.

Fox Chase Cancer Center’s Jaye Gardiner Receives Award for Outstanding Postdoc From the American Society for Cell Biology

September 30th 2022

Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center, was recently awarded the Merton Bernfield Memorial Award from the American Society for Cell Biology, making her one of 18 scientists from across the country to be recognized for their achievements in the life sciences.

Fox Chase Cancer Center Welcomes Dr. Anthony M. Villano

September 26th 2022

Fox Chase Cancer Center is pleased to announce the hiring of Anthony M. Villano, MD, as a clinical instructor in the Department of Surgical Oncology.

Fox Chase Researchers Discover How Pancreatic Cancer Cells Manage to Survive in Poor Nutritional Environments

September 13th 2022

In a recent study, researchers at Fox Chase Cancer Center demonstrated how cancer cells can survive in the body even when faced with a lack of sufficient nutrition, a finding that could be used as a potential indicator of disease status in the organs of pancreatic cancer patients.

Lapatinib May Boost Effectiveness of Drugs That Destroy Cancer Proteins by Blocking Resistance

September 2nd 2022

Researchers at Fox Chase Cancer Center have discovered that the drug efflux pump MDR1 promotes resistance to a promising new class of drugs called PROTACS—proteolysis-targeting chimeras.

Elizabeth Plimack, MD, MS, Appointed Deputy Director at Fox Chase Cancer Center

April 19th 2022

Elizabeth Plimack, MD, MS, chief of the Division of Genitourinary Medical Oncology and professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been appointed Deputy Director.